Section Ph 2107.02 - Performance of Inspections(a) Inspections shall be performed, after presentation of proper identification, by pharmacy board investigators, inspectors, or commissioners, and he or she shall have access to all records concerning the purchase, storage, labeling, distribution, compounding, reconstitution, and disposal of prescription drugs.(b) Inspections for licensees of the boards included in RSA 318:8-a and RSA 318:9-a, shall include: (1) Verification of active DEA number and prescription monitoring program registration and all delegates;(2) General facility and security related to the practice of pharmacy;(3) Proper storage of medications;(4) Proper labeling of medications;(5) Complete record keeping of distribution of control drug medications;(6) Proper disposal of medications; and(7) Purchasing information of medications.(c) Inspections for licensees involved with non-hazardous sterile and non-sterile compounding of medications as stated in 318:14-a shall include: (1) Verification of patient specific medications;(2) Purchasing information from pharmacy board-licensed wholesaler/manufacturer;(3) Training of personnel in aseptic technique and available for review;(4) Standards of practice policy and procedure for injectable or intravenous medications; and(5) Policy and procedure to ensure environment meets minimum requirements related to the practice of pharmacy.(d) Inspections for licensees involved with hazardous sterile compounding of medications as stated in 318:14-a shall include: (1) Demonstrated adherence with Ph 404 standards concerning sterile compounding;(2) Be licensed with the pharmacy board as an institutional pharmacy/infusion center;(3) Policies and procedures for hazardous spills related to the practice of pharmacy; and(4) The spill kit in the facility.N.H. Admin. Code § Ph 2107.02
Derived from Volume XL Number 19, Filed May 7, 2020, Proposed by #13028, Effective 4/11/2020, Expires 4/11/2030.